NEXAVAR may cause birth defects or death of an unborn baby. Avoid becoming pregnant while taking NEXAVAR and for at least 2 weeks after stopping your treatment. Men and women should use birth control during and at least 2 weeks after NEXAVAR therapy. Call your doctor right away if you become pregnant. Do not breastfeed while taking NEXAVAR as this medication may be passed through breast milk. continue reading below »
A diagnosis of advanced kidney cancer may be overwhelming. It may help to know you are not alone. Because symptoms can take a while to develop, nearly a third of people find out they have kidney cancer only after it has progressed.1 For these patients, there are many treatment options available.
You will need to work closely with your doctor to develop the most appropriate course of treatment. Nexavar may play an important role, either as the first treatment you receive or it may be included after other treatments. Speak with your doctor about if and when Nexavar might fit into your treatment plan.Read more about:
References: 1. Escudier B, Eisen T, Stadler WM, et al. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol. 2009;27(20):3312-3318. 2. American Cancer Society. Overview: kidney cancer. How is kidney cancer treated? ACS Web site. http://www.cancer.org/docroot/CRI/content /CRI_2_2_4x_ How_Is_Kidney_Cancer_Treated.asp?rnav=cri. Updated May 14, 2009. Accessed August 6, 2009.